Alta Natural News Conference Announced, Breakthrough Hepatitis-C Treatment to be Unveiled.

--(BUSINESS WIRE)--Nov. 12, 1998--

Alta Natural (Alberta Stock Exchange:AHS.)

Adolph Huckschlag, company president, is pleased to announce that long-awaited results from clinical and pre-clinical trials done on their Hepatitis-C product, Hepatico, will be released at press conferences in Vancouver and Seattle. The dates are: -0-

Vancouver, B.C:   Monday, Nov. 16, 1998
                  Robson Square Conference Center
                  Conference Room No. 4
                  10 a.m.

Seattle, WA:      Tuesday Nov. 17, 1998
                  Seattle Westin
                  Room to be posted
                  2 p.m.

The company will be releasing the results of 17 clinical and pre-clinical trials conducted in Europe on the efficacy of Hepatico in the treatment of serious liver disease including Hepatitis-C. In addition, the company will release the preliminary results of their non-clinical test currently underway in North America. The summary results will also be released worldwide via their Internet site at www.alta-natural.com.

IMPORTANT: Due to sheer size of and demand for the trial material, anyone, including members of the media, are required to RSVP the company to ensure availability of all support material. Only those who RSVP prior to the press conferences can be guaranteed full documentation.